Evidence map›Paper›PMID 24158961›Full record

ReviewJournal of leukocyte biology2014

HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies.

Paul R Gorry, Nicholas Francella, Sharon R Lewin, Ronald G Collman

Abstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Animal models for studies of HIV-1 brain reservoirs.Journal of leukocyte biology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Effects of HIV on metabolic and biological pathways of CD4Experimental and therapeutic medicine · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Paediatric HIV infection: the potential for cure.Nature reviews. Immunology · 2016
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paul R Gorry1.GPO Box 2284, Melbourne 3001, Victoria, Australia. gorry@burnet.edu.au or University of Pennsylvania, 522 Johnson Pavilion, 36th and Hamilton Walk, Philadelphia, PA 19104-6060, USA. E-mail: collmanr@mail.med.upenn.edu.
Nicholas Francella
Sharon R Lewin
Ronald G Collman

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
TRAINING IN HIV PATHOGENESIST32AI007632 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Frederic D Bushman, James L. Riley · 2000 to 2026
$10.6M
HIV: gp120, Chemokine Receptors &Macrophage ActivationR01MH061139 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1999 to 2015
$5.2M
Entry Coreceptor Use & Target Cell Tropism in Nonpathogenic SIV InfectionR56AI091516 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 2011 to 2011
$449k
The role of chemokines in the establishment of HIV latencyR56AI095073 · NIAID · MONASH UNIVERSITY · PI LEWIN, SHARON RUTH · 2012 to 2012
$271k
NIAID NIH HHS AI045008NIAID NIH HHS AI091516NIAID NIH HHS P30 AI045008NIAID NIH HHS R56 AI091516NIAID NIH HHS R56 AI095073NIAID NIH HHS T32 AI007632NIAID NIH HHS T32-AI007632NIAID NIH HHS U19 AI096109NIH HHS P51 OD011104NIMH NIH HHS MH061139NIMH NIH HHS R01 MH061139
6 · The paper itself

Abstract

Myeloid cells residing in the CNS and lymphoid tissues are targets for productive HIV-1 replication, and their infection contributes to the pathological manifestations of HIV-1 infection. The Envs can adopt altered configurations to overcome entry restrictions in macrophages via a more efficient and/or altered mechanism of engagement with cellular receptors. This review highlights evidence supporting an important role for macrophages in HIV-1 pathogenesis and persistence, which need to be considered for strategies aimed at achieving a functional or sterilizing cure. We also highlight that the molecular mechanisms underlying HIV-1 tropism for macrophages are complex, involving enhanced and/or altered interactions with CD4, CCR5, and/or CXCR4, and that the nature of these interactions may depend on the anatomical location of the virus.

Indexed as

Antiretroviral Therapy, Highly ActiveCD4 AntigensDisease ProgressionHematopoietic Stem Cell TransplantationHIV-1HIV Envelope Protein gp120HIV InfectionsHumansMacrophagesMonocytesReceptors, CCR5Receptors, CXCR4Receptors, VirusViral TropismVirus InternalizationVirus LatencyCD4 AntigensHIV Envelope Protein gp120Receptors, CCR5Receptors, CXCR4Receptors, VirusCCR5CD4CXCR4reservoir

Identifiers

PMID24158961
PMCPMC3868190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.